Letermovir Injection and Moxetumomab Pasudotox-tdfk
Determining the interaction of Letermovir Injection and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letermovir
Brand name: Prevymis
Synonyms: Letermovir (oral/injection), Letermovir
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Letermovir Injection-Moxetumomab pasudotox-tdfk Intravenous
- Letermovir Injection-Moxifloxacin
- Letermovir Injection-Moxifloxacin (Systemic)
- Letermovir Injection-Moxifloxacin Hydrochloride
- Letermovir Injection-Moxifloxacin Injection
- Letermovir Injection-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Letermovir Intravenous
- Moxetumomab Pasudotox-tdfk-Letermovir oral/injection
- Moxetumomab Pasudotox-tdfk-Letermovir Tablets
- Moxetumomab Pasudotox-tdfk-Letrozole
- Moxetumomab Pasudotox-tdfk-Letrozole and ribociclib
- Moxetumomab Pasudotox-tdfk-Leucovorin